Efficacy and safety of various anti-rheumatic treatments for patients with rheumatoid arthritis: a network meta-analysis.
Conclusions: We recommend CZP + MTX as the optimal drug therapy because it has the highest ranking in efficacy outcomes and relatively low risk of adverse events. TCZ + MTX is recommended as an alternative. Abatacept (ABT) and cDMARDs are not recommended due to their low efficacy.
PMID: 30697252 [PubMed]
Source: Archives of Medical Science - Category: General Medicine Tags: Arch Med Sci Source Type: research
More News: Abatacept | Actemra | Arthritis | Biomedical Science | General Medicine | Methotrexate | Orencia | Pain | Rheumatoid Arthritis | Rheumatology | Science | Study